Tolerance Induction with Agonist Peptides Recognized by Autoaggressive Lymphocytes is Transient: Therapeutic Potential for Type 1 Diabetes is Limited and Depends on Time-point of Administration, Choice of Epitope and Adjuvant

Author: von Herrath M.G.   Coon B.   Wolfe T.  

Publisher: Academic Press

ISSN: 0896-8411

Source: Journal of Autoimmunity, Vol.16, Iss.3, 2001-05, pp. : 193-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content